RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
0.825
+0.018 (2.18%)
At close: Dec 20, 2024, 4:00 PM
0.850
+0.024 (2.93%)
After-hours: Dec 20, 2024, 5:08 PM EST
RAPT Therapeutics Employees
RAPT Therapeutics had 131 employees as of December 31, 2023. The number of employees increased by 34 or 35.05% compared to the previous year.
Employees
131
Change (1Y)
34
Growth (1Y)
35.05%
Revenue / Employee
n/a
Profits / Employee
-$820,550
Market Cap
28.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
IRIDEX | 111 |
IGC Pharma | 67 |
Curis | 49 |
Calidi Biotherapeutics | 41 |
Chemomab Therapeutics | 20 |
OneMedNet | 20 |
RenovoRx | 8 |
Intensity Therapeutics | 7 |
RAPT News
- 5 weeks ago - Rapt Therapeutics Stock Plummets, Terminates Asthma Trial Due To Patient's Liver Injury - Benzinga
- 5 months ago - RAPT: CCR4 Inhibition Presses On For Now With Oncology Focus - Seeking Alpha
- 7 months ago - Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB) - Benzinga
- 7 months ago - RAPT Therapeutics: Dip Following FDA Clinical Hold Creates Asymmetric Opportunity - Seeking Alpha
- 8 months ago - RAPT Therapeutics Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 9 months ago - RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients - GlobeNewsWire
- 9 months ago - VKTX, JANX and these biotech stocks are surging in 2024 - Invezz
- 10 months ago - RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire